Cargando…
Phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis: -KOGC04-
BACKGROUND: In patients with highly advanced gastric cancer, the recurrence rate remains high and the prognosis disappointing. We previously reported a phase I study of a neoadjuvant chemoradiotherapy of S-1 plus weekly cisplatin. Although adequate safety and efficacy were reported, myelosuppression...
Autores principales: | Matsuda, Satoru, Takahashi, Tsunehiro, Fukada, Junichi, Fukuda, Kazumasa, Kawakubo, Hirofumi, Saikawa, Yoshiro, Kawaguchi, Osamu, Takeuchi, Hiroya, Shigematsu, Naoyuki, Kitagawa, Yuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904203/ https://www.ncbi.nlm.nih.gov/pubmed/24398302 http://dx.doi.org/10.1186/1748-717X-9-9 |
Ejemplares similares
-
Correction: phase I study of neoadjuvant chemoradiotherapy with S-1 plus biweekly cisplatin for advanced gastric cancer patients with lymph node metastasis -KOGC04-
por: Matsuda, Satoru, et al.
Publicado: (2014) -
A Highly Advanced Gastric Cancer Maintaining a Clinical Complete Response after Chemoradiotherapy Comprising S-1 and Cisplatin
por: Yura, Masahiro, et al.
Publicado: (2018) -
Salvage endoscopic resection as a treatment for locoregional failure or recurrence following chemoradiotherapy or radiotherapy for esophageal cancer
por: NAKAMURA, RIEKO, et al.
Publicado: (2016) -
CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma
por: Irino, Tomoyuki, et al.
Publicado: (2014) -
CXCL12 expression promotes esophageal squamous cell carcinoma proliferation and worsens the prognosis
por: Uchi, Yusuke, et al.
Publicado: (2016)